In April 2023, U.S. District Court Judge Matthew Kacsmaryk set off a national media firestorm when he issued a ruling that could—if it ever took effect—threaten nationwide access to mifepristone, one of the drugs taken as part of a two-drug regimen to procure a chemical abortion.
But Kacsmaryk’s nationwide injunction was stayed by the Supreme Court and never took effect.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



